Soufflé Therapeutics
Boston, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $200M
Overview
A small molecule drug discovery company targeting difficult-to-drug proteins in cancer and inflammation.
OncologyImmunology
Technology Platform
An integrated platform using structural biology and computational design to develop small molecule inhibitors of challenging protein targets.
Funding History
1Total raised:$200M
Venture$200M
Opportunities
Proven clinical efficacy for its lead candidate could lead to lucrative partnership or acquisition deals in the high-value oncology market.
Risk Factors
High risk of clinical failure inherent in novel oncology targets and intense competition from both small molecules and biologics in its chosen areas.
Competitive Landscape
Competes with numerous other small molecule discovery biotechs and large pharma, where success hinges on clinical validation of novel mechanisms.